Drugmaker Merck is in advanced talks to buy cancer-focused biotech company Seagen in a deal that could be worth $40 billion or more, the Wall Street Journal reports https://t.co/jKzyi3hecQ pic.twitter.com/icY2J0zP0T— Reuters (@Reuters) July 7, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


